Pharmacological modulation of immunoreactive imidazoline receptor proteins in rat brain: Relationship with non-adrenoceptor [3H]-idazoxan binding sites

British Journal of Pharmacology

Volumn 118, Issue 8, 1996, Pages 2029-2036

  Escribá, Pablo V ^a   Alemany, Regina ^a   Sastre, Magdalena ^a   Olmos, Gabriel ^a   Ozaita, Andrés ^a   García Sevilla, Jesús A ^a  

^a UNIVERSITAT DE LES ILLES BALEARS   (Spain)

Author keywords

I2 sites; Imidazoline receptor proteins; Rat brain; 3H idazoxan

Indexed keywords

2 (2 BENZOFURANYL)IMIDAZOLE; 2 (2 METHOXY 1,4 BENZODIOXAN 2 YL) 2 IMIDAZOLINE; 2 ETHOXY 1(2H) QUINOLINECARBOXYLIC ACID ETHYL ESTER; CIRAZOLINE; CLORGYLINE; EFAROXAN; IDAZOXAN; IMIDAZOLINE RECEPTOR; PHENELZINE; UNCLASSIFIED DRUG; YOHIMBINE;

ANIMAL TISSUE; ARTICLE; BINDING SITE; BRAIN; BRAIN CORTEX; CONTROLLED STUDY; IMMUNOBLOTTING; LONG TERM CARE; MALE; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN MODIFICATION; RAT; RECEPTOR AFFINITY; RECEPTOR DENSITY;

EID: 0029828431     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15640.x     Document Type: Article

References (48)

1. ALEMANY, R., ESCRIBÁ P.V., SASTRE, M., OLMOS, G., OZAITA, A. & GARCÍA-SEVILLA, J.A. (1995a). Pharmacological modulation of immunoreactive 29/30, 45 and 66 kDa imidazoline receptor proteins in the rat brain. Meth. Find. Exp. Clin. Pharmacol., 17, Suppl. A, 70.
2. 2 receptors, on glial fibrillary acidic protein concentration. Eur. J. Pharmacol., 280, 205-210.
3. 2 imidazoline-preferring receptors. Br. J. Pharmacol., 114, 837-845.
4. ALLAN, D.R., PENNER, S.B. & SMYTH, D.D. (1996). Antagonism by idazoxan at low dose but not high dose, of the natriuretic action of moxonidine. Br. J. Pharmacol., 117, 29-34.
5. BACH, A.W., LAN, N.C., JOHNSON, P.L., ABELL, C.W., BEMBENEK, M.E., KWAN, S.W., SEEBURG, P.H. & SMITH, J.C. (1988). cDNA cloning of human liver monoamine oxidase A and B. Molecular basis of differences in enzymatic properties. Proc. Natl. Acad. Sci. U.S.A., 85, 4934-4938.
6. BOUSQUET, P., FELDMAN, J. & SCHWARTZ, J. (1984). Central cardiovascular effects of α-adrenergic drugs: differences between catecholamines and imidazolines. J. Pharmacol. Exp. Ther., 230, 232-242.
7. 2 sites. J. Pharmacol. Exp. Ther., 272, 681-688.
8. 2-sites. Br. J. Pharmacol., 112, 1065-1070.
9. DIAMANT, S., ELDAR-GEVA, T. & ATLAS, D. (1992). Imidazoline binding sites in human placenta: evidence for heterogeneity and a search for physiological function. Br. J. Pharmacol., 106, 101-108.
10. ESCRIBÁ, P.V., OZAITA, A., MIRALLES. A., REIS, D.J. & GARCÍA-SEVILLA, J.A. (1995a). Molecular characterization and isolation of a 45-kilodalton imidazoline receptor protein from the rat brain. Mol. Brain Res., 32, 187-196.
11. ESCRIBÁ, P.V., SASTRE, M. & GARCÍA-SEVILLA, J.A. (1994a). Increased density of guanine nucleotide-binding (G) proteins in the postmortem brain of heroin addicts. Arch. Gen. Psychiatry, 151, 494-501.
12. ESCRIBÁ, P.V., SASTRE, M. & GARCÍA-SEVILLA, J.A. (1995b). Disruption of cellular signaling pathways by daunomycin through destabilization of non-lamellar membrane structures. Proc. Natl. Acad. Sci. U.S.A., 92, 7595-7599.
13. ESCRIBÁ, P.V., SASTRE, M., WANG, H., REGUNATHAN, S., REIS, D.J. & GARĆIA-SEVILLA, J.A. (1994b). Immunodetection of putative imidazoline receptor proteins in the human and rat brain and other tissues. Neurosci. Lett., 178, 81-84.
14. EVINGER, M.J., ERNSBERGER, P., REGUNATHAN, S. & REIS, D.J. (1995). Regulation of phenylethanolamine N-methyltransferase gene expression by imidazoline receptors in adrenal chromaffin cells. J. Neurochem., 65, 988-997.
15. GARCÍA-SEVILLA, J.A., ESCRIBÁ, P.V., SASTRE, M., WALZER, C., BUSQUETS, X., JAQUET, G., REIS, D.J. & GUIMÓN, J. (1996). Immunodetection and quantitation of imidazoline receptor proteins in platelets of patients with major depression and in brains of suicide victims. Arch. Gen. Psychiatry, (in press).
16. 3H]-idazoxan. Neurosci. Lett., 184, 133-136.
17. 2-adrenoceptor-independent inhibition of noradrenaline release by imidazoline derivatives. Naunyn-Schmiedeberg's Arch. Pharmacol., 343, 271-282.
18. GRENEY, H., BENNAI, F., MOLINES, A., BELCOURT, A., DONTENWILL, M. & BOUSQUET, P. (1994). Isolation of human cerebral imidazoline-specific binding protein. Eur. J. Pharmacol., 265, R1-R2.
19. 2-adrenergic receptor. Science, 238, 650-656.
20. LANIER, S.M., IVKOVIC, B., SINGH, I., NEUMEYER, J.L. & BAKTHAVACHALAM, V. (1993). Visualization of multiple imidazoline/guanidinium-receptive sites. J. Biol. Chem., 268, 16047-16051.
21. LANIER, B., RADDATZ, R., BAKTHAVACHALAM, V., COUPRY, I., NEUMEYER, J.L. & LANIER, S.M. (1995). Structural and ligand recognition properties of imidazoline binding proteins in tissues of rat and rabbit. Mol. Pharmacol., 48, 703-710.
22. LI, G., REGUNATHAN, S., BARROW, C.J., ESHRAGHI, J , COOPER, R. & REIS, D.J. (1994). Agmatine: an endogenous clonidine-displacing substance in the brain. Science, 263, 966-969.
23. LIMON, I., COUPRY, I., LANIER, S.M. & PARINI, A. (1992). Purification and characterization of mitochondrial imidazoline-guanidinium receptive site from rabbit kidney. J. Biol. Chem., 267, 21645-21649.
24. LOWRY, O.H., ROSEBROUGH, N.J., FARR, A.C. & RANDALL, R.J. (1951). Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193, 265-275.
25. 2) imidazoline affinity in rat kidney. Br. J. Pharmacol., 115, 72P.
26. MICHEL, M.C. & ERNSBERGER, P. (1992). Keeping an eye on the I site: Imidazoline-preferring receptors. Trends Pharmacol. Sci., 13, 369-370.
27. 3H]RX821002 (2-methoxy idazoxan) in the human and rat brains. J. Pharmacol. Exp. Ther., 264, 1187-1197.
28. 2-imidazoline sites in vitro and in vivo. J. Neurochem., 61, 1602-1610.
29. 2-imidazoline binding sites. NaunynSchmiedeberg's Arch. Pharmacol., 351, 507-516.
30. 1-imidazoline sites in bovine adrenal medullary membranes. Naunyn-Schmiedeberg's Arch. Pharmacol., 348, 70-76.
31. OLMOS, G., ALEMANY, R., ESCRIBÁ, P.V. & GARCÍA-SEVILLA, J.A. (1994a). The effects of chronic imidazoline drug treatment on glial fibrillary acidic protein concentrations in rat brain. Br. J. Pharmacol., 111, 997-1002.
32. 3H]-idazoxan binding sites in the rat brain. Br. J. Pharmacol., 108, 597-603.
33. 2 receptors. Eur. J. Pharmacol., 262, 41-48.
34. PARINI, A., GARGALIDIS MOUDANOS, C., PIZZINAT, N. & LANIER, S.M. (1996). The elusive family of imidazoline binding sites. Trends Pharmacol. Sci., 17, 13-16.
35. PILETZ, J.E., CHIKKALA, D.N. & ERNSBERGER, P. (1995). Comparison of the properties of agmatine and endogenous clonidine-displacing substance at imidazoline and alpha-2 adrenergic receptors. J. Pharmacol. Exp. Ther., 272, 581-587.
36. PINEDA, J., UGEDO, L. & GARCÍA-SEVILLA, J.A. (1993). Stimulatory effects of clonidine, cirazoline and rilmenidine on locus coeruleus noradrenergic neurones: possible involvement of imidazoline-preferring receptors. Naunyn-Schmiedeberg's Arch. Pharmacol., 348, 134-140.
37. RADDATZ, R., PARINI, A. & LANIER, S.M. (1995). Imidazoline/ guanidinium binding domains on monoamine oxidases. Relationship to subtypes of imidazoline-binding proteins and tissuespecific interaction of imidazoline ligands with monoamine oxidase B. J. Biol. Chem., 270, 27961-27968.
38. REGUNATHAN, S., FEINSTEIN, D.L. & REIS, D.J. (1993). Expression of non-adrenergic imidazoline sites in rat cerebral cortical astrocytes. J. Neurosci. Res., 34, 681-688.
39. REIS, D.J., BOUSQUET, P. & PARINI, A. ed. (1995). The Imidazoline Receptor: Pharmacology, Functions, Ligands, and Relevance to Biology and Medicine. In Ann. New York Acad. Sci., Vol. 763.
40. 2-imidazoline receptors in the frontal cortex of suicide victims. Ann. New York Acad. Sci., 763, 520-522.
41. 2-adrenoceptors and monoamine oxidase B in brains of suicide victims. Neurochem. Inter., (in press).
42. 2-imidazoline receptors in the postmortem brains of heroin addicts. NeuroReport, 7, 509-512.
43. 2-adrenoceptors are blocked. Naunyn-Schmiedeberg's Arch. Pharmacol., 340, 712-714.
44. 2-imidazoline binding sites on monoamine oxidases. J. Biol. Chem., 270, 9856-9861.
45. TIBIRIÇA, E., FELDMAN, J., MERMET, C., GONON, F. & BOUSQUET, P. (1991). An imidazoline-specific mechanism for the hypotensive effect of clonidine: a study with yohimbine and idazoxan. J. Pharmacol. Exp. Ther., 256, 606-613.
46. 2c-adrenoceptors and non-adrenergic imidazoline sites in the guinea pig. Pharmacol. Toxicol., 76, 353-364.
47. WANG, H., REGUNATHAN, S., MEELEY, M.P. & REIS, D.J. (1992). Isolation and characterization of imidazoline receptor protein from bovine adrenal chromaffin cells. Mol. Pharmacol., 42, 792-801.
48. WANG, H., REGUNATHAN, S., RUGGIERO, D.A. & REIS, D.J. (1993). Production and characterization of antibodies specific for the imidazoline receptor protein. Mol. Pharmacol., 43, 509-515.